Dr. Tim Coté, the Director of FDA Office of Orphan Products Development (OOPD) introduces Chuck and his son, Charlie, to the OOPD staff. Chuck talks about a family history of DMD and how Charlie was first diagnosed by elevated creatine phosphokinase blood levels.
